1. ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the;Circulation,2016
2. ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;European Heart Journal,2017
3. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationThe Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);European Heart Journal,2021
4. Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease;Eur Heart J,2022
5. Chinese Society of Cardiology and Chinese College of Cardiovascular Physicians Expert Consensus statement on dual antiplatelet therapy in patients with coronary artery disease;Atherosclerosis, Coronary Heart Disease Working Group of Chinese Society of C, Interventional Cardiology Working Group of Chinese Society of C, Specialty Committee on P, Treatment of Thrombosis of Chinese College of Cardiovascular P, Specialty Committee on Coronary Artery D;Zhonghua Xin Xue Guan Bing Za Zhi,2021